Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
BPfectin Transfection Reagent is a specially designed and synthesized cationic polymer formulation which offers extremely high transfection efficiencies of 293 suspension cells in serum-free CD 293 TGE Medium. It is available separately or as part of the Power 293 Expression System.
BPfectin Transfection Reagent can be used as transfection reagent for DNA delivery to different cell lines including HEK293, CHO-K1, 3T3, A549 and Hela cells. The proprietary formulation of the transfection reagent enable ultra-low cytotoxicity to cells post transfection and compatible with serum. It is suitable for academic research, stable transfection and transient expression production. Detailed transfection protocols on your application may vary and needs to be developed.
• Support high efficient transfection of mammalian cells in suspension and adherent culture
• Ultra low cytotoxicity versus competitive alternatives and conventional cationic polymers
• Scalable from culture plate to large scale stirred bioreactor
• Ultra stable and long shell life
• Chemically define and regulatory friendly
| Product Classification | Cell Type | Regulatory Statement | Shelf Life | ||||
| Chemically Defined, Animal Origin-Free | Established Cell Lines | For Research Use Only | 12 months | ||||
| Cat. No. | Name of Product | Product Size | Storage | Shipping | |||
| TF-1157-11 | BPfectin Transfection Reagent | 1.5mL | at -20°C | 2-8°C | |||
Table 1:Ratio for transfection complexes formation
| Plasmid for Transfection | 293 Expression MAX-1 | BPfectin | 293 Culture | ||||
| 10μg | 4μL | 30μL | 10 million cells | ||||
• Before transfection, passage 293 cells with CD 293 TGE Medium for at least 3 round from an adaptation procedure, seeding density greater than 0.5 ×106 cells/ml, cell viability >95%. Culture at 150-180 rpm depending on your orbital shaker design and single cell distribution status.
• Seed 293 cells at 0.5 ×106 cells/ml and transfer to pre-warmed fresh medium, subsequently grow the cells to 1.5 to 2.2 ×106 cells/ml.
• The day before transfection, dilute the culture with fresh medium to 0.8 to 1.0 ×106 cells/ml and cell density at transfection should range from 1.5 × 106 to 2.0 × 106 cells/ml, provided the doubling time is 24 h and viability is greater than 95%.
• On the day of transfection, using sterile 150 mM NaCl solution to dilute DNA plasmid and add 293 Expression MAX-1 (Catalog # EXP-711) according to the instruction.
• Add BPfectin (Catalog # TF-1157) at ratio of 3:1 (BPfectin : DNA; volume/weight) to DNA solution mix well with vortex for 3 sec.
Note: DNA dosage for transfection is 1 ug per 1 million cells in culture, and volume of DNA-BPfectin complexes is 5%(v/v) of culture. (e.g. 500 μL to 10 mL culture).
• Incubate the complexes at RT for 10 min before transfection.
• Add DNA-BPfectin complexes to cells at 5% volume ratio mix well gently.
• 24 hours post transfection, add Feed X Supplement (Catalog # CF-1116) to culture at 10% volume ratio (e.g. 1 mL to 10mL culture).
• Harvest for purification typically 7 days post transfection or when cell viability drops below 55%.
| Cat. No. | Product Name | Quantity | Storage Conditions |
|---|---|---|---|
| TF-1157-11 | BPfectin | 1.5 mL | -20°C |
| EXP-711-11 | 293 Expression MAX-1 | 1 mL | -20°C |
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
To enable antibody characterization methodsACROBiosystems has developed a series of enzymes.such as ldeS, SpeB, EndoH, and Endo S proteases, toassist with the characterization of antibodies and theirrelated post-translational modifications (PTMs)
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2， CD133, GPRC5D，CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides innovative solutions for neuroscience research. Recombinant proteins, neural factors, pre-formed fibrils, electrophysiological electrodes, as well as Organoid Toolbox all in Aneuro aiming to advance neuroscience research, develop therapeutic interventions, and improve diagnostic methods for neurological diseases.
This web search service is supported by Google Inc.
A-Z
